Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.6K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

1.9K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex.

Nature·2026
Same author

Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine development.

Cell reports·2026
Same author

Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies.

Immunity·2026
Same author

Ultra-high-throughput IGH genotyping of 25 global populations reveals population-biased allelic diversity and homozygous V and D gene deletions.

Immunity·2026
Same author

The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients.

Clinical & translational immunology·2026
Same author

Population-level genomic analysis of immunoglobulin loci variation in rhesus macaques reveals extensive germline diversity.

Immunity·2026

Related Experiment Video

Updated: Mar 8, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K

Evolution of B cell analysis and Env trimer redesign.

Gunilla B Karlsson Hedestam1, Javier Guenaga2, Martin Corcoran1

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Immunological Reviews
|January 31, 2017
PubMed
Summary

Developing effective HIV-1 vaccines is challenging due to the virus's immune evasion strategies. This review explores HIV-1 envelope glycoprotein (Env) immunogenicity and novel B cell analysis tools for vaccine design.

Keywords:
HIV-1epitoperepertoirevaccineB cellantibody

More Related Videos

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

10.1K

Related Experiment Videos

Last Updated: Mar 8, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

10.1K

Area of Science:

  • Immunology and Virology
  • Vaccine Design and Development

Background:

  • Human immunodeficiency virus type 1 (HIV-1) utilizes surface envelope glycoproteins (Env), gp120 and gp41, to evade immune responses.
  • The virus establishes chronic infections, driving the selection of immune-resistant variants that maintain infectivity.
  • Targeting the functional Env entry unit with antibodies is difficult, posing a significant hurdle for vaccine development.

Purpose of the Study:

  • To review key aspects of HIV-1 Env immunogenicity and immunogen re-design strategies.
  • To provide rationale for using novel tools to analyze B cell responses in the context of vaccine development.
  • To explore opportunities for addressing challenges in eliciting effective B cell immunity against HIV-1.

Main Methods:

  • Review of experimental data on HIV-1 Env immunogenicity and immunogen design over the past decade.
  • Analysis of newly evolving tools for studying B cell responses.
  • Application of next-generation sequencing for antibody lineage tracing and B cell fate mapping.

Main Results:

  • HIV-1 Env glycoproteins have evolved sophisticated immune evasion mechanisms.
  • Systematic approaches to immunogen design are crucial for overcoming these challenges.
  • Advanced B cell analysis tools offer new insights into vaccine-induced immune responses.

Conclusions:

  • Developing effective vaccines against HIV-1 remains a significant scientific challenge.
  • Novel immunogen design and advanced B cell analysis are critical for progress.
  • These developments hold promise for establishing effective B cell immunity against HIV-1 and potentially other viruses.